HOTTEST PENNY STOCK PICKS

[mtrendspotter]

$MFST ON ALERT Medifirst Solutions Company Update
Freehold, NJ, July 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST
SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of
innovative laser technology with its FDA 510(k) cleared Infrared Time Machine
TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty
Pharmacy Drug Consulting Services and Distributor of USA Premium Hemp and CBD
products, is pleased to provide a company update.

Medifirst Solutions previously announced that they have been approved for
credit card processing for its USA Premium CBD & Hemp products division. The
CBD and Hemp products include a 500mg oil, 1000mg oil and a premium 6000mg
oil. In addition to the oils, also called tinctures, the company is selling
CBD and Hemp Mints.

We are pleased to announce that we anticipate going live and rolling out our
products within the next two weeks online at www.usapremiumcbd.com as well as
several additional satellite websites to be announced. In addition, we plan to
launch online sales for our Hemp products to be available on Amazon.com.
Commented CEO Bruce J. Schoengood, “We are very excited to be launching our
CBD line of oils and mints and we believe we have outstanding quality products
all backed up by independent lab testing. In additional to our current line of
oils and mints, the company plans to develop and distribute its own line of
cosmetic CBD products, several new CBD liquid products and several creams and
oils for pain.” The Company plans on announcing further details in the
upcoming days and weeks.

Recent industry projections forecast the CBD market to hit 16 billion dollars
by 2025. Continues Schoengood, “This industry is very young and there is great
interest in CBD and Hemp products. Our mission is to develop and market high
quality products that consumers can trust and all backed up by independent lab
testing. We believe that adding high quality and some unique CBD and Hemp
products to our product line is a great compliment to our therapeutic Infrared
Time Machine Laser used for helping people who suffer from pain and
inflammation.”

Regarding our Laser Division, Medifirst is pleased to announce that company
representatives are currently in China performing laser tests and trial
treatments for a healthcare group that plans to open over 1,000 pain centers
across the country. In China, there is a great demand for all natural and
drug-free solutions to both chronic and everyday pain and we believe our FDA
cleared Time Machine 810nm Infrared laser can provide a useful and effective
tool for healthcare professionals. At this time, there is no guarantee of a
final agreement and we will announce further updates as we progress.

Medifirst is also pleased to announce a possible new expansion and direction
for our Therapeutic Laser. Although there are many applications and protocols
for laser as related to pain and inflammation, we were most excited by the
recent application of Photobiomodulation (PBM) to treat a side effect of
cancer therapy called Oral Mucositis. This is an area that presents very a
promising usage of our 810nm Laser as patients often develop painful or
debilitating ulcers in the soft tissues within the oral cavity. According to
industry statistics, Oral Mucositis affects roughly 400,000 patients annually
in the United States, affecting their cheeks, lips, gums, inner cavity and
tonsilary region which includes all of the soft tissues. Treatment options
today are rather limited. Patients are usually given pain medication and/or
antiseptic mouthwash. Beyond that, there's not much doctors can do for the
painful condition that, at advanced stages, can inhibit a patient's ability to
eat and speak. We believe that laser therapy can be effective in treating Oral
Mucositis and the Company is working with industry professionals to advance
and explore using laser technology for this condition. Medifirst anticipates
further updates and announcements in the upcoming days and weeks to the above
mentions updates as well to our Specialty Pharma Consulting division.


https://www.bloomberg.com/press-releases/2019-07-17/medifirst-solutions-company-update